Veflox Adverse Reactions

500 mg: 1% to 10%: Cardiovascular: Chest pain (1%), edema (1%).
Central nervous system: Headache (6%), insomnia (4%), dizziness (3%), fatigue (1%), pain (1%).
Dermatologic: Rash (2%), pruritus (1%).
Gastrointestinal: Nausea (7%), diarrhea (5%), constipation (3%), abdominal pain (2%), dyspepsia (2%), vomiting (2%).
Genitourinary: Vaginitis (1%).
Local: Injection site reaction (1%).
Respiratory: Pharyngitis (4%), dyspnea (1%).
Miscellaneous: Monilias (1%).
<1%: Limited to important or life-threatening: Acute renal failure, agitation, agranulocytosis; allergenic reaction (including anaphylaxis, angioedema, pneumonitis rash, pneumonitis, and serum sickness); anaphylactoid reaction, arrhythmia (including atrial/ventricular tachycardia/fibrillation and torsade de pointes), aplastic anemia, arthralgia, ascites, bradycardia, bronchospasm, carcinoma, cardiac failure, cholecystitis, cholelithiasis, confusion, depression, EEG abnormalities, encephalopathy, eosinophilia, erythema multiforme, GI hemorrhage, granulocytopenia, hallucination, heart block, hemolytic anemia, hemoptysis, hepatic failure (some fatal), hepatitis, hyper-/hypoglycemia, hyperkalemia, hyperkinesias, hyper-/hypotension, infection, INR increased, intestinal obstruction, intracranial hypertension, involuntary muscle contractions, jaundice, leukocytosis, leukopenia, leucorrhea, lymphadenopathy, MI, migraine, multiple organ failure, myalgia, nephritis (interstitial), palpitation, pancreatitis, pancytopenia, paralysis, paresthesia, peripheral neuropathy, photosentivity (<0.1%), pleural effusion, pneumonititis, postural hypotension, prothrombin time increased/decreased, pseudomembraneous colitis, psychosis, pulmonary edema, pulmonary embolism, purpura, QT_c prolongation, respiratory depression, rhabdomyolysis, seizure, skin disorder, somnolence, speech disorder, Stevens-Johnson syndrome, stupor, suicide attempt/ideation, syncope, tendonitis, tendon rupture, tongue edema, toxic epidermal necrolysis, transaminases increased, thrombocythemia, thrombocytopenia, tremor, urticaria, WBC abnormality.
750 mg: Common: Gastrointestinal: Diarrhea (5%), nausea (7%).
Neurologic: Dizziness (3%), headache (6% to 10%), insomnia (4%).
Serious: Cardiovascular: Aortic aneurysm, or dissection, cardiac arrest (0.1% to 1%), prolonged QT interval, torsades de pointes, ventricular tachycardia (0.1% to 1%).
Dermatologic: Erythema multiforme, Stevens-Johnson syndrome.
Endocrine metabolic: Hypoglycemia (0.1% to 1%).
Hematologic: Aplastic anemia, pancytopenia, thrombocytopenia purpura.
Hepatic: Hepatitis, liver failure.
Immunologic: Anaphylactoid reaction, hypersensitivity reaction (0.1% to 1%).
Musculoskeletal: Exacerbation of myasthenia gravis, rupture of tendon, tendinitis (0.1% to 1%).
Neurologic: Disorientated, disturbance of attention, Guillain-Barré syndrome, memory impairment, peripheral neuropathy, pseudotumor cerebri, raised intracranial pressure, seizure (0.1% to 1%).
Ophthalmic: Retinal detachment.
Psychiatric: Delirium, depression (0.1% to 1%), hallucinations (0.1% to 1%), paranoid disorder, psychotic disorder, suicidal.
Renal: Renal failure (0.1% to 1%).